SlideShare uma empresa Scribd logo
1 de 61
Baixar para ler offline
Coordinating Multiple
    Stakeholders
         April 10-12, 2012
  Walt Disney World Swan Resort
Learning Objectives:
1. Describe the relationship between prescription
drug morbidity and mortality and the under-
treatment of pain.
2. Identify measurement-based care as standard
of care in pain medicine and describe how to
measure pain, mood and function in every
clinical encounter.
3. Evaluate how new state and federal policy
changes will likely allow more prudent and safer
use of opioids for chronic, non-cancer pain.
Disclosure Statement
•  All presenters for this session, Dr. Alex
   Cahana and Dr. Gary M. Franklin, have
   disclosed no relevant, real or apparent
   personal or professional financial
   relationships.
UW Pain Care Delivery
      Program
    acahana@uw.edu
John	
  J.	
  Bonica	
  
UW	
  Division	
  of	
  Pain	
  Medicine	
  &	
  Affiliates
                                                                        	
  


                                                                                                                      APCA
                                                                                                         BCNH
                                                                                            MHCS                       UAA
                                                                                                          IIPM
                                                                                                                      ANMC




                                       Inpatient
Inpatient    Inpatient    Inpatient                              Inpatient                 Inpatient
                                       (Seattle)




                                                    Outpatient                Outpatient                Outpatient   Outpatient




                                       Outpatient
Outpatient   Outpatient   Outpatient   (Seattle &                Outpatient                Outpatient
                                          AL)
My disclosures

•  I	
  am	
  not	
  opio-­‐phobic	
  
•  I	
  am	
  not	
  opio-­‐philic	
  
•  I	
  am	
  not	
  needle-­‐phobic	
  
•  I	
  am	
  not	
  needle-­‐philic	
  
•  I	
  am	
  agnos3c	
  to	
  chi	
  gong	
  and	
  tai	
  chi	
  
•  ‘I	
  just	
  wanna	
  know	
  how	
  my	
  pa3ents	
  are	
  doin’	
  
•  Because	
  if	
  I	
  don’t	
  measure	
  outcome	
  I	
  believe	
  my	
  prac3ce	
  is	
  not	
  
   medically,	
  financially	
  or	
  ethically	
  sustainable	
  
•  Standard	
  of	
  Care	
  needs	
  to	
  be	
  codified	
  
Today:
                                    	
  

•    Situa3on	
  
•    Model	
  of	
  Care	
  
•    Value	
  
•    Future	
  
Overtreatment	
  is	
  the	
  new	
  under-­‐treatment
                                                     	
  
132 to 1775




690 to 1,442
Opioid	
  AddicEon	
  Treatment
                              	
  
Serious Morbidity ICD-9 CM:
"Diagnosis Codes: Respiratory insufficiency or failure: 518.5, 518.81,518.82, 518.5, 786.09; Aspiration pneumonia
507.0; Anoxic encephalopathy: 348.1; Cardiac Arrest: 427.5; Rhabdomyolysis: 728.88, 728.89"Procedure Codes:
Endotracheal administration: 96.04; Mechanical ventilation: 96.70-96.72; CPR: 93.93, 99.60
Data Sources: Comprehensive Hospital Abstract Reporting System (CHARS)
Oregon, State Inpatient Database (SID), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare
Research and Quality.
Opioid	
  Related	
  Deaths
                           	
  




2001- 265          2009- 644
Opioid Overdose Risk (fatal & non-fatal) by
                 Average
              Opioid	
  overdose/death	
  raEo 	
  
Daily Dose of Medically Prescribed Opioids
     10                                                          9-fold increase
      9                                             **            in risk relative
                                                                   to low-dose
      8
                                                                     patients
      7                                             1.79 %
      6
      5
      4                                 **
      3                                 0.68 %                 ** Significant
      2                                                            increment in
                                                                   risk p<0.05
      1    0.04 %             0.26 %
                     0.16 %
      0
          Non-user 1-19 mg. 20-49 mg. 50-99 mg. 100+ mg.


                                                 Dunn et al., Annals Int Med, 2010
Fracture	
  Hazard	
  RaEo	
  

2.5
                                                              2-fold increase
                                            **                in risk relative
 2                                                             to non-users
                                          10.0 %
1.5
                               7.0 %
 1
                    5.7 %
       3.8 %                                              ** Significant
                                                             increment in risk
0.5                                                           p<0.05


 0
      Non-user     1-19 mg.   20-49 mg.   50+ mg.


                                                   Saunders et al., JGIM, 2010
Adverse	
  selecEon:
                                     	
  
70.0%
                                            61.4%
60.0%
                                51.7%
50.0%
                   38.5%
40.0%

30.0%   26.8%                                                 Odds ratios
                                                              adjusted for
          1.0        1.4         2.1          2.6             pain severity
20.0%
                                                              and patient
                                                              characteristics
10.0%

0.0%
        1-19 mg   20-49 mg.   50-119 mg.   120+ mg.
                                                      Merrill et al., under review
Newborns	
  with	
  Drug	
  Withdrawal	
  (GeneraEon	
  Rx)	
  	
  
                Washington	
  State,	
  1990-­‐2009	
  
                                               5	
  




                                               4	
  
  Rate	
  per	
  1,000	
  live	
  births	
  




                                               3	
  




                                               2	
  




                                               1	
  




                                               0	
  
                                                       1990	
     1992	
     1994	
     1996	
     1998	
     2000	
     2002	
     2004	
     2006	
     2008	
  




Source: Washington State Department of Health, Comprehensive Hospital Abstract Reporting System
WA	
  State	
  Healthy	
  Youth	
  Survey              	
  
Frequency	
  of	
  Use	
  to	
  Get	
  High	
  Past	
  30	
  days	
  Grade	
  10	
  




                                               Sabel J, Banta-Green C. CSTE
                                               2009
84'-%)45$9
    ;)<-'(*$6%2
      =&&-5-4'(
"
             @,2
          J0-%$&0
          L$HI"M

             @,2
          L$HI"M
             K;/

           @,2
              :
       P$*"-$"Q
              %&

          @,2.*
          S..%+%
    !"#$%&"'(%)
    UR1&-2"=10-'
"
$$$$$$$$$$$$$$$$$$$@-3
More	
  opioids,	
  more	
  addicEon,	
  more	
  deaths
                                                      	
  
• People die from Rx
       100                Overdoses Every
                          Day in the US



                                  • Rx Pain Killer
      14,800                       Deaths in
                                   2008
Source: CDC Vital Signs: overdoses of prescription opioid pain relievers -
1999-2008
For Every One Death :


 10 Treatment     32 Emergency
 admissions for      dept visits
    abuse
             1 Death

130 People who                             825 Non-
 Misuse/abuse                             medical users

Source: CDC Vital Signs: overdoses of prescription opioid pain relievers -
1999-2008
Cultural Transformation
Today:
                                    	
  

•    Situa3on	
  
•    Model	
  of	
  Care	
  
•    Value	
  
•    Future	
  
Revise	
  our	
  pracEce	
  model	
  


•  System is                 •  Coordinated care
   fragmented                   (PCMH)
                                 Patient activation
•  Care is inconsistent
                             •  Collaborative care
                                (Telepain/ECHO)
•  Cost is
   unsustainable             •  Measurement based
                                care (CPAIN /
                                PainTracker)
Coordinated,	
  CollaboraEve	
  Pain	
  Management
                                                        	
  

                                        The Patient
Measurement-Based Care                                                 Prescription Monitoring Tools

                                        Primary
                                         Care
                                       Providers

                                     Nurse Care
                                     Coordinator
     Pain                                 s                                              UDT
   Tracker                                                                               EDIE
    CPAIN                                                                                PMP
    DNIC
                                        Pain
                                      Specialists


                                                                Structured
                     2ndOpinion        TelePain              Interdisciplinary
                     RX Reviews   Consultation & CME                Pain
                                                              Management
                                  Increasing Level of Care
                                        Lower Costs
1. Care Coordination
Workflow
CPR = Center for Pain Relief
NCC = Nurse Care Coordinator
PCP = Primary Care Provider
2.	
  ECHO/TelePain/ROAM	
  
“MulEplier	
  Effect”
                                      	
  

               (&)*$+'                       3..#)/$&"'
                !&,*,'                       (&)*$+,'#$'
             (-*,*$+*.'                       (-&%)%*'
              +/'0!12'
!"#$#%#&$'




!"#$#%#&$'
 
3.	
  PaEent	
  reported	
  outcome
Today:
                                    	
  

•    Situa3on	
  
•    Model	
  of	
  Care	
  
•    Value	
  
•    Future	
  
1.	
  Coordinated	
  Care	
  

            n=3500
1.	
  Coordinated	
  care:	
  Pilot	
  data




                   Pain    Disability   Anxiety   Depression   Opioid use

Well engaged       -6%       -45%        -44%       -50%         -56%
 Minimally
 engaged          +28%       +55%        +10%       +28%          +1%
Not engaged       +29%       +29%       No f/u      No f/u        -3%
2.	
  ECHO/TelePain/ROAM	
  

•    40-­‐50	
  dial-­‐ins	
  each	
  session	
  
•    1500	
  providers	
  	
  
•    76	
  loca3ons	
  
•    2240	
  CME	
  hours	
  
•    Regional	
  ‘Pain	
  champions’	
  (meta-­‐ECHO)	
  
2.	
  ECHO/TelePain/ROAM	
  

                              N = 94
                                                       N = 95
          6                  Mean	
  =	
  4.7
                                                     Mean = 4.5
                                                                                N = 94
                             SD = 0.6                                         Mean = 4.3
                                                      SD = 0.7
                                                                               SD = 0.7
          5


          4
        Mean Rating




          3


          2


          1


          0
                      Learning best practice    Developing clinical    Comfortable teaching
                              care                  expertise         others what I've learned


Participants Rated Level of Agreement on a 5-point Scale: 1 = Not At All, 5 = To a Large Degree
2.	
  ECHO/TelePain/ROAM	
  
                       N = 85           N = 84           N = 84          N = 85         N = 86
                     Mean = 4.6                                        Mean = 4.4
     6                                 Mean = 4.3      Mean = 4.4                     Mean = 4.5
                      SD = 0.7          SD =0.7         SD = 0.7        SD = 4.5       SD = 0.6

     5

     4
   Mean Rating




     3

     2

     1

     0
                     Reduced           Reduced        Provider's      Decreased     Through early
                 patient travel for   emergency     appropriate use    visits by    and effective
                  specialty care      room visits      of testing     patients to      patient
                   and testing                                        specialists   interventions




Providers Rated Agreement on a 5-point Scale: 1 = Strongly Disagree, 5 = Strongly Agree
2.	
  ECHO/TelePain/ROAM	
  

                                                                                                   2007-­‐2009	
  
25	
  
                            41%	
  *	
  
20	
                                                                                               2008-­‐20010	
  
                                                                 54%	
  *	
  
                                            	
  63%	
  *	
  
15	
  
                                                                                               29%	
  
          34%	
  
10	
  
                                                                                43%	
  *	
  

  5	
  

  0	
  
          State	
  	
     Clallam	
  	
       Grant	
          Jefferson	
       Kitsap	
   Okanogan	
  
3.	
  PaEent	
  Reported	
  Outcome	
  
3.	
  PaEent	
  Reported	
  Outcome	
  
3.	
  PaEent	
  Reported	
  Outcome	
  




Estimated Savings per Claim over Duration of   ER Group (N = 373)   ID Group (N = 373)   DR Group (N = 373)
Disability
Total Cost of Illness per Claim (2010 US $)         $66,525             $121,829             $233,600

   Average Savings                                     -                 $55,304             $167,075

   % Saved                                             -                   45%                  72%

                                                                                         Theodore, in press
Today:
                                    	
  

•    Situa3on	
  
•    Model	
  of	
  Care	
  
•    Value	
  
•    Future	
  
Scalability	
  and	
  sustainability	
  

•    State	
  (WA,	
  AK)	
  
•    DoD/VA	
  	
  
•    Large	
  employers	
  (UW,	
  GE)	
  
•    CMS/CMMI	
  
WA	
  State	
  legislaEon	
  (2876):	
  	
  


•    Mandates	
  Educa3on	
  and	
  Guidelines	
  
•    Mandates	
  TeleHealth	
  	
  
•    Mandates	
  Opioid	
  tracking	
  	
  
•    Mandates	
  Measurement	
  at	
  each	
  encounter	
  
Most	
  emphasis
               	
  
NaEonal	
  legislaEon	
  

•    Educa3on	
  -­‐	
  7	
  (CA,	
  FL,	
  ME,	
  NY,	
  UT,	
  WA,	
  WV)	
  
•    TeleHealth	
  -­‐	
  5	
  (KS,	
  ME,	
  MN,	
  NM,	
  WA)	
  
•    Monitoring	
  Program	
  -­‐	
  48	
  (NH,	
  MS	
  pending)	
  
•    Outcome	
  tracking	
  -­‐	
  1	
  (WA)	
  
Mandatory	
  guidelines:
                       	
  
2009-­‐2010:	
  Deaths	
  from	
  opioids	
  decreased	
  by	
  50%	
  
State	
  ED	
  informaEon	
  exchange	
  

                                                                                                     No controlled
Registration Reveals                                       Physician reviews                         substances
                       Patient’s ED chart                  ED care guidelines
Patient on EDIE
                       flagged for doctor                                        medical screening
                                            Usual Triage                         exam by ED physician




                                                                           ED case manager talks to
                                                                           patient prior to discharge




                                                                                Patient Discharged
State	
  ED	
  informaEon	
  exchange	
  
           “Please	
  review	
  
             Jane	
  Doe”	
  




                                   24 hour referral line    compiled and
                                                                                    Reviewed for appropriateness      Program Coordinator
                                                            researched.
ED Physician                                                                                                               calls PCP




                                                                                                      PCP
                                                                                                 Recommendations




                                                           ED Care Guidelines Committee
 ED Care Guidelines                                        Chaplin     ED Nurse      ED Physicians
                                                                                                              Patient’s Primary Care Physician

                                                           Psych Nurse Pharmacist    Medical Director
EDIE:	
  Reducing	
  Non-­‐Emergent	
  ED	
  UElizaEon	
  
Revise	
  our	
  pracEce	
  model	
  


•  System is                 •  Coordinated care
   fragmented                   (PCMH)
                                 Patient activation
•  Care is inconsistent
                             •  Collaborative care
                                (TelePain/ECHO)
•  Cost is
   unsustainable             •  Measurement based
                                care (CPAIN/
                                PainTracker)
EducaEon	
  is	
  important	
  




                          Rosenblatt, 2011
!"#$%&%'#(')$*+$#,-'.*/)(#$")*0',"*+$#,-,"$*/(%1$2*3"45678**

                                                                                       Current Level of Knowledge1   Level of Interest in
                                                                                                                        Learning 2

                                                                                                                         Mean (SD)
                                                                                                Mean (SD)

Assessment and management of genetic-biologic-psychological-social components                    2.18 (1.0)              4.25 (0.85)
commonly involved in development and maintenance of complex chronic pain
disorders


Pathophysiology of chronic pain versus acute pain                                                2.34 (1.0)              4.25 (0.85)


Use, interpretation, and application of measurement based tools when completing a                1.72 (0.9)              4.16 (0.88)
comprehensive pain assessment

Multispecialty treatments and approaches for the care of chronic pain                            2.12 (1.0)              4.37 (0.75)


Types and roles of medications used for pain, including opioids and non-opioids.                 2.29 (1.1)              4.56 (0.63)


Types and role of non-medication treatment for chronic pain                                      2.23 (1.0)              4.52 (0.70)


Common primary care clinical pain disorders                                                      2.43 (1.0)              4.35 (0.85)


Pain Medicine as a chronic illness specialty with knowledge and skills including                 2.02 (1.1)              3.84 (1.06)
diagnosis of complex complaints, complex medical and surgical illnesses, and both
consultative and continuing multidisciplinary treatment.


Learning more about pursuing a Residency in Pain Medicine                                            -                   2.85 (1.35)
!
*
1 Scale = 1-Poor, 2-Fair, 3-Good, 4-Very Good, 5-Excellent
2 Scale = 1-Not Interested, 2-Little Interest, 3-Neutral, 4-Somewhat Interested, 5-Very Interested
But	
  not	
  enough	
  
Take	
  Home	
  Message:
                                           	
  

•  Coordinated,	
  collabora3ve,	
  measurement	
  based	
  model:	
  

•    50%	
  decrease	
  in	
  deaths	
  from	
  opioids	
  
•    65%	
  decrease	
  in	
  coun3es	
  par3cipa3ng	
  in	
  TelePain	
  
•    56%	
  decrease	
  in	
  opioid	
  prescrip3on	
  rate	
  
•    56%	
  decrease	
  in	
  opioid	
  related	
  ER	
  visits	
  
•    50%	
  increase	
  in(see attached, for North American
     Spine Society 2012 Outstanding Paper Award)	
  global	
  
     health	
  ra3ng	
  1	
  year	
  aker	
  treatment	
  
It	
  ain't	
  what	
  you	
  
    don't	
  know	
  that	
  
    gets	
  you	
  into	
  
    trouble.	
  	
  
It's	
  what	
  you	
  know	
  
    for	
  sure	
  that	
  just	
  
    ain't	
  so.	
  

                    Mark	
  Twain	
  

Mais conteúdo relacionado

Destaque

Richard Victor
Richard VictorRichard Victor
Richard VictorOPUNITE
 
Carol Boyd
Carol BoydCarol Boyd
Carol BoydOPUNITE
 
Mike Townsend
Mike TownsendMike Townsend
Mike TownsendOPUNITE
 
Michael-Ward
Michael-WardMichael-Ward
Michael-WardOPUNITE
 
Rollin Gallagher
Rollin GallagherRollin Gallagher
Rollin GallagherOPUNITE
 
Gary Martin2
Gary Martin2Gary Martin2
Gary Martin2OPUNITE
 
Joseph Paduda
Joseph PadudaJoseph Paduda
Joseph PadudaOPUNITE
 
Sarah Melton
Sarah MeltonSarah Melton
Sarah MeltonOPUNITE
 
Benson-Marshall-Matthew
Benson-Marshall-MatthewBenson-Marshall-Matthew
Benson-Marshall-MatthewOPUNITE
 
Robert Sproul
Robert SproulRobert Sproul
Robert SproulOPUNITE
 
Leslie Balonick
Leslie BalonickLeslie Balonick
Leslie BalonickOPUNITE
 
Karen Perry
Karen PerryKaren Perry
Karen PerryOPUNITE
 
Dr. Ileana Arias
Dr. Ileana AriasDr. Ileana Arias
Dr. Ileana AriasOPUNITE
 
Michelle Lipinski
Michelle LipinskiMichelle Lipinski
Michelle LipinskiOPUNITE
 
Kelly Clark
Kelly ClarkKelly Clark
Kelly ClarkOPUNITE
 
Heuser-Desmond
Heuser-DesmondHeuser-Desmond
Heuser-DesmondOPUNITE
 
Gary Franklin
Gary FranklinGary Franklin
Gary FranklinOPUNITE
 
CLAAD/ Safe BTW
CLAAD/ Safe BTWCLAAD/ Safe BTW
CLAAD/ Safe BTWOPUNITE
 
Andrew Kolodny
Andrew KolodnyAndrew Kolodny
Andrew KolodnyOPUNITE
 

Destaque (20)

Richard Victor
Richard VictorRichard Victor
Richard Victor
 
Carol Boyd
Carol BoydCarol Boyd
Carol Boyd
 
Mike Townsend
Mike TownsendMike Townsend
Mike Townsend
 
Michael-Ward
Michael-WardMichael-Ward
Michael-Ward
 
Ismposter
Ismposter Ismposter
Ismposter
 
Rollin Gallagher
Rollin GallagherRollin Gallagher
Rollin Gallagher
 
Gary Martin2
Gary Martin2Gary Martin2
Gary Martin2
 
Joseph Paduda
Joseph PadudaJoseph Paduda
Joseph Paduda
 
Sarah Melton
Sarah MeltonSarah Melton
Sarah Melton
 
Benson-Marshall-Matthew
Benson-Marshall-MatthewBenson-Marshall-Matthew
Benson-Marshall-Matthew
 
Robert Sproul
Robert SproulRobert Sproul
Robert Sproul
 
Leslie Balonick
Leslie BalonickLeslie Balonick
Leslie Balonick
 
Karen Perry
Karen PerryKaren Perry
Karen Perry
 
Dr. Ileana Arias
Dr. Ileana AriasDr. Ileana Arias
Dr. Ileana Arias
 
Michelle Lipinski
Michelle LipinskiMichelle Lipinski
Michelle Lipinski
 
Kelly Clark
Kelly ClarkKelly Clark
Kelly Clark
 
Heuser-Desmond
Heuser-DesmondHeuser-Desmond
Heuser-Desmond
 
Gary Franklin
Gary FranklinGary Franklin
Gary Franklin
 
CLAAD/ Safe BTW
CLAAD/ Safe BTWCLAAD/ Safe BTW
CLAAD/ Safe BTW
 
Andrew Kolodny
Andrew KolodnyAndrew Kolodny
Andrew Kolodny
 

Semelhante a Alex Cahana

Appropriateness of Admissions in a Ward of Internal Medicine on a Second-Care...
Appropriateness of Admissions in a Ward of Internal Medicine on a Second-Care...Appropriateness of Admissions in a Ward of Internal Medicine on a Second-Care...
Appropriateness of Admissions in a Ward of Internal Medicine on a Second-Care...Javier Rodriguez-Vera
 
The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...HTAi Bilbao 2012
 
Session 7 - Patient Centered Care
Session 7 - Patient Centered CareSession 7 - Patient Centered Care
Session 7 - Patient Centered CareMedXellence
 
Campo, Luis - Technologies in Personalized Medicine
Campo, Luis - Technologies in Personalized MedicineCampo, Luis - Technologies in Personalized Medicine
Campo, Luis - Technologies in Personalized Medicineponencias_mihealth2012
 
Quality of underground health care: A case study of Indian RMPs
Quality of underground health care: A case study of Indian RMPsQuality of underground health care: A case study of Indian RMPs
Quality of underground health care: A case study of Indian RMPsJeff Knezovich
 
Imrt Symposia Global Overview
Imrt Symposia Global OverviewImrt Symposia Global Overview
Imrt Symposia Global Overviewfondas vakalis
 
M Doutlook 2009 Melanoma Physicians Report
M Doutlook  2009 Melanoma   Physicians ReportM Doutlook  2009 Melanoma   Physicians Report
M Doutlook 2009 Melanoma Physicians Reportrstephan2269
 
Accidents In Radiation Therapy
Accidents In Radiation TherapyAccidents In Radiation Therapy
Accidents In Radiation Therapyfondas vakalis
 
New Drug Opportunity Assessments Strat Planning For Future Success
New Drug Opportunity Assessments  Strat Planning For Future SuccessNew Drug Opportunity Assessments  Strat Planning For Future Success
New Drug Opportunity Assessments Strat Planning For Future SuccessPharmacision LLC
 
Advances in Preventing HIV Transmission Using Antiretroviral Therapy: The Rol...
Advances in Preventing HIV Transmission Using Antiretroviral Therapy: The Rol...Advances in Preventing HIV Transmission Using Antiretroviral Therapy: The Rol...
Advances in Preventing HIV Transmission Using Antiretroviral Therapy: The Rol...Clinical Care Options
 
Trius sept12confpresentation
Trius sept12confpresentationTrius sept12confpresentation
Trius sept12confpresentationCompany Spotlight
 
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...Irma Kirtadze M.D.
 
CAND Posters 2011
CAND Posters 2011CAND Posters 2011
CAND Posters 2011CCNM
 
CAND POSTERS 2011
CAND POSTERS 2011CAND POSTERS 2011
CAND POSTERS 2011CCNM
 
As munich 2013 4.0
As munich 2013 4.0As munich 2013 4.0
As munich 2013 4.0mmoreno2013
 
R. Gil Kerlikowske
R. Gil KerlikowskeR. Gil Kerlikowske
R. Gil KerlikowskeOPUNITE
 
health financing summit by Dr. Madz Valera
health financing summit by Dr. Madz Valerahealth financing summit by Dr. Madz Valera
health financing summit by Dr. Madz Valerapsecp
 

Semelhante a Alex Cahana (20)

Chronic Opioid Therapy
Chronic Opioid TherapyChronic Opioid Therapy
Chronic Opioid Therapy
 
Appropriateness of Admissions in a Ward of Internal Medicine on a Second-Care...
Appropriateness of Admissions in a Ward of Internal Medicine on a Second-Care...Appropriateness of Admissions in a Ward of Internal Medicine on a Second-Care...
Appropriateness of Admissions in a Ward of Internal Medicine on a Second-Care...
 
The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...
 
Session 7 - Patient Centered Care
Session 7 - Patient Centered CareSession 7 - Patient Centered Care
Session 7 - Patient Centered Care
 
Campo, Luis - Technologies in Personalized Medicine
Campo, Luis - Technologies in Personalized MedicineCampo, Luis - Technologies in Personalized Medicine
Campo, Luis - Technologies in Personalized Medicine
 
Quality of underground health care: A case study of Indian RMPs
Quality of underground health care: A case study of Indian RMPsQuality of underground health care: A case study of Indian RMPs
Quality of underground health care: A case study of Indian RMPs
 
Dmt g pday_oct12
Dmt g pday_oct12Dmt g pday_oct12
Dmt g pday_oct12
 
Imrt Symposia Global Overview
Imrt Symposia Global OverviewImrt Symposia Global Overview
Imrt Symposia Global Overview
 
M Doutlook 2009 Melanoma Physicians Report
M Doutlook  2009 Melanoma   Physicians ReportM Doutlook  2009 Melanoma   Physicians Report
M Doutlook 2009 Melanoma Physicians Report
 
Accidents In Radiation Therapy
Accidents In Radiation TherapyAccidents In Radiation Therapy
Accidents In Radiation Therapy
 
New Drug Opportunity Assessments Strat Planning For Future Success
New Drug Opportunity Assessments  Strat Planning For Future SuccessNew Drug Opportunity Assessments  Strat Planning For Future Success
New Drug Opportunity Assessments Strat Planning For Future Success
 
Advances in Preventing HIV Transmission Using Antiretroviral Therapy: The Rol...
Advances in Preventing HIV Transmission Using Antiretroviral Therapy: The Rol...Advances in Preventing HIV Transmission Using Antiretroviral Therapy: The Rol...
Advances in Preventing HIV Transmission Using Antiretroviral Therapy: The Rol...
 
Trius sept12confpresentation
Trius sept12confpresentationTrius sept12confpresentation
Trius sept12confpresentation
 
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...
 
CAND Posters 2011
CAND Posters 2011CAND Posters 2011
CAND Posters 2011
 
CAND POSTERS 2011
CAND POSTERS 2011CAND POSTERS 2011
CAND POSTERS 2011
 
HFS Valera
HFS ValeraHFS Valera
HFS Valera
 
As munich 2013 4.0
As munich 2013 4.0As munich 2013 4.0
As munich 2013 4.0
 
R. Gil Kerlikowske
R. Gil KerlikowskeR. Gil Kerlikowske
R. Gil Kerlikowske
 
health financing summit by Dr. Madz Valera
health financing summit by Dr. Madz Valerahealth financing summit by Dr. Madz Valera
health financing summit by Dr. Madz Valera
 

Mais de OPUNITE

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynoteOPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynoteOPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynoteOPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_finalOPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerOPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyOPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliOPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesOPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceOPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleOPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattOPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerOPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_groupOPUNITE
 

Mais de OPUNITE (20)

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 

Último

Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...Garima Khatri
 
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiAlinaDevecerski
 
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service KochiLow Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service KochiSuhani Kapoor
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...chandars293
 
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Dipal Arora
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableNehru place Escorts
 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...hotbabesbook
 
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escortsaditipandeya
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...CALL GIRLS
 
Call Girls Bareilly Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bareilly Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Bareilly Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bareilly Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...Neha Kaur
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Servicevidya singh
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...astropune
 

Último (20)

Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
 
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
 
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service KochiLow Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
 
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service Available
 
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
 
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
 
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
 
Call Girls Bareilly Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bareilly Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Bareilly Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bareilly Just Call 9907093804 Top Class Call Girl Service Available
 
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
 

Alex Cahana

  • 1. Coordinating Multiple Stakeholders April 10-12, 2012 Walt Disney World Swan Resort
  • 2. Learning Objectives: 1. Describe the relationship between prescription drug morbidity and mortality and the under- treatment of pain. 2. Identify measurement-based care as standard of care in pain medicine and describe how to measure pain, mood and function in every clinical encounter. 3. Evaluate how new state and federal policy changes will likely allow more prudent and safer use of opioids for chronic, non-cancer pain.
  • 3. Disclosure Statement •  All presenters for this session, Dr. Alex Cahana and Dr. Gary M. Franklin, have disclosed no relevant, real or apparent personal or professional financial relationships.
  • 4. UW Pain Care Delivery Program acahana@uw.edu
  • 6. UW  Division  of  Pain  Medicine  &  Affiliates   APCA BCNH MHCS UAA IIPM ANMC Inpatient Inpatient Inpatient Inpatient Inpatient Inpatient (Seattle) Outpatient Outpatient Outpatient Outpatient Outpatient Outpatient Outpatient Outpatient (Seattle & Outpatient Outpatient AL)
  • 7. My disclosures •  I  am  not  opio-­‐phobic   •  I  am  not  opio-­‐philic   •  I  am  not  needle-­‐phobic   •  I  am  not  needle-­‐philic   •  I  am  agnos3c  to  chi  gong  and  tai  chi   •  ‘I  just  wanna  know  how  my  pa3ents  are  doin’   •  Because  if  I  don’t  measure  outcome  I  believe  my  prac3ce  is  not   medically,  financially  or  ethically  sustainable   •  Standard  of  Care  needs  to  be  codified  
  • 8. Today:   •  Situa3on   •  Model  of  Care   •  Value   •  Future  
  • 9. Overtreatment  is  the  new  under-­‐treatment  
  • 10. 132 to 1775 690 to 1,442
  • 12. Serious Morbidity ICD-9 CM: "Diagnosis Codes: Respiratory insufficiency or failure: 518.5, 518.81,518.82, 518.5, 786.09; Aspiration pneumonia 507.0; Anoxic encephalopathy: 348.1; Cardiac Arrest: 427.5; Rhabdomyolysis: 728.88, 728.89"Procedure Codes: Endotracheal administration: 96.04; Mechanical ventilation: 96.70-96.72; CPR: 93.93, 99.60 Data Sources: Comprehensive Hospital Abstract Reporting System (CHARS) Oregon, State Inpatient Database (SID), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality.
  • 13. Opioid  Related  Deaths   2001- 265 2009- 644
  • 14. Opioid Overdose Risk (fatal & non-fatal) by Average Opioid  overdose/death  raEo   Daily Dose of Medically Prescribed Opioids 10 9-fold increase 9 ** in risk relative to low-dose 8 patients 7 1.79 % 6 5 4 ** 3 0.68 % ** Significant 2 increment in risk p<0.05 1 0.04 % 0.26 % 0.16 % 0 Non-user 1-19 mg. 20-49 mg. 50-99 mg. 100+ mg. Dunn et al., Annals Int Med, 2010
  • 15. Fracture  Hazard  RaEo   2.5 2-fold increase ** in risk relative 2 to non-users 10.0 % 1.5 7.0 % 1 5.7 % 3.8 % ** Significant increment in risk 0.5 p<0.05 0 Non-user 1-19 mg. 20-49 mg. 50+ mg. Saunders et al., JGIM, 2010
  • 16. Adverse  selecEon:   70.0% 61.4% 60.0% 51.7% 50.0% 38.5% 40.0% 30.0% 26.8% Odds ratios adjusted for 1.0 1.4 2.1 2.6 pain severity 20.0% and patient characteristics 10.0% 0.0% 1-19 mg 20-49 mg. 50-119 mg. 120+ mg. Merrill et al., under review
  • 17. Newborns  with  Drug  Withdrawal  (GeneraEon  Rx)     Washington  State,  1990-­‐2009   5   4   Rate  per  1,000  live  births   3   2   1   0   1990   1992   1994   1996   1998   2000   2002   2004   2006   2008   Source: Washington State Department of Health, Comprehensive Hospital Abstract Reporting System
  • 18. WA  State  Healthy  Youth  Survey   Frequency  of  Use  to  Get  High  Past  30  days  Grade  10   Sabel J, Banta-Green C. CSTE 2009
  • 19. 84'-%)45$9 ;)<-'(*$6%2 =&&-5-4'( " @,2 J0-%$&0 L$HI"M @,2 L$HI"M K;/ @,2 : P$*"-$"Q %& @,2.* S..%+% !"#$%&"'(%) UR1&-2"=10-' " $$$$$$$$$$$$$$$$$$$@-3
  • 20. More  opioids,  more  addicEon,  more  deaths  
  • 21. • People die from Rx 100 Overdoses Every Day in the US • Rx Pain Killer 14,800 Deaths in 2008 Source: CDC Vital Signs: overdoses of prescription opioid pain relievers - 1999-2008
  • 22. For Every One Death : 10 Treatment 32 Emergency admissions for dept visits abuse 1 Death 130 People who 825 Non- Misuse/abuse medical users Source: CDC Vital Signs: overdoses of prescription opioid pain relievers - 1999-2008
  • 24. Today:   •  Situa3on   •  Model  of  Care   •  Value   •  Future  
  • 25.
  • 26. Revise  our  pracEce  model   •  System is •  Coordinated care fragmented (PCMH) Patient activation •  Care is inconsistent •  Collaborative care (Telepain/ECHO) •  Cost is unsustainable •  Measurement based care (CPAIN / PainTracker)
  • 27. Coordinated,  CollaboraEve  Pain  Management   The Patient Measurement-Based Care Prescription Monitoring Tools Primary Care Providers Nurse Care Coordinator Pain s UDT Tracker EDIE CPAIN PMP DNIC Pain Specialists Structured 2ndOpinion TelePain Interdisciplinary RX Reviews Consultation & CME Pain Management Increasing Level of Care Lower Costs
  • 28. 1. Care Coordination Workflow CPR = Center for Pain Relief NCC = Nurse Care Coordinator PCP = Primary Care Provider
  • 30. “MulEplier  Effect”   (&)*$+' 3..#)/$&"' !&,*,' (&)*$+,'#$' (-*,*$+*.' (-&%)%*' +/'0!12' !"#$#%#&$' !"#$#%#&$'
  • 32.
  • 33.
  • 34.
  • 35.
  • 36. Today:   •  Situa3on   •  Model  of  Care   •  Value   •  Future  
  • 38. 1.  Coordinated  care:  Pilot  data Pain Disability Anxiety Depression Opioid use Well engaged -6% -45% -44% -50% -56% Minimally engaged +28% +55% +10% +28% +1% Not engaged +29% +29% No f/u No f/u -3%
  • 39. 2.  ECHO/TelePain/ROAM   •  40-­‐50  dial-­‐ins  each  session   •  1500  providers     •  76  loca3ons   •  2240  CME  hours   •  Regional  ‘Pain  champions’  (meta-­‐ECHO)  
  • 40. 2.  ECHO/TelePain/ROAM   N = 94 N = 95 6 Mean  =  4.7 Mean = 4.5 N = 94 SD = 0.6 Mean = 4.3 SD = 0.7 SD = 0.7 5 4 Mean Rating 3 2 1 0 Learning best practice Developing clinical Comfortable teaching care expertise others what I've learned Participants Rated Level of Agreement on a 5-point Scale: 1 = Not At All, 5 = To a Large Degree
  • 41. 2.  ECHO/TelePain/ROAM   N = 85 N = 84 N = 84 N = 85 N = 86 Mean = 4.6 Mean = 4.4 6 Mean = 4.3 Mean = 4.4 Mean = 4.5 SD = 0.7 SD =0.7 SD = 0.7 SD = 4.5 SD = 0.6 5 4 Mean Rating 3 2 1 0 Reduced Reduced Provider's Decreased Through early patient travel for emergency appropriate use visits by and effective specialty care room visits of testing patients to patient and testing specialists interventions Providers Rated Agreement on a 5-point Scale: 1 = Strongly Disagree, 5 = Strongly Agree
  • 42. 2.  ECHO/TelePain/ROAM   2007-­‐2009   25   41%  *   20   2008-­‐20010   54%  *    63%  *   15   29%   34%   10   43%  *   5   0   State     Clallam     Grant   Jefferson   Kitsap   Okanogan  
  • 43. 3.  PaEent  Reported  Outcome  
  • 44. 3.  PaEent  Reported  Outcome  
  • 45. 3.  PaEent  Reported  Outcome   Estimated Savings per Claim over Duration of ER Group (N = 373) ID Group (N = 373) DR Group (N = 373) Disability Total Cost of Illness per Claim (2010 US $) $66,525 $121,829 $233,600 Average Savings - $55,304 $167,075 % Saved - 45% 72% Theodore, in press
  • 46. Today:   •  Situa3on   •  Model  of  Care   •  Value   •  Future  
  • 47. Scalability  and  sustainability   •  State  (WA,  AK)   •  DoD/VA     •  Large  employers  (UW,  GE)   •  CMS/CMMI  
  • 48. WA  State  legislaEon  (2876):     •  Mandates  Educa3on  and  Guidelines   •  Mandates  TeleHealth     •  Mandates  Opioid  tracking     •  Mandates  Measurement  at  each  encounter  
  • 50. NaEonal  legislaEon   •  Educa3on  -­‐  7  (CA,  FL,  ME,  NY,  UT,  WA,  WV)   •  TeleHealth  -­‐  5  (KS,  ME,  MN,  NM,  WA)   •  Monitoring  Program  -­‐  48  (NH,  MS  pending)   •  Outcome  tracking  -­‐  1  (WA)  
  • 52. 2009-­‐2010:  Deaths  from  opioids  decreased  by  50%  
  • 53. State  ED  informaEon  exchange   No controlled Registration Reveals Physician reviews substances Patient’s ED chart ED care guidelines Patient on EDIE flagged for doctor medical screening Usual Triage exam by ED physician ED case manager talks to patient prior to discharge Patient Discharged
  • 54. State  ED  informaEon  exchange   “Please  review   Jane  Doe”   24 hour referral line compiled and Reviewed for appropriateness Program Coordinator researched. ED Physician calls PCP PCP Recommendations ED Care Guidelines Committee ED Care Guidelines Chaplin ED Nurse ED Physicians Patient’s Primary Care Physician Psych Nurse Pharmacist Medical Director
  • 56. Revise  our  pracEce  model   •  System is •  Coordinated care fragmented (PCMH) Patient activation •  Care is inconsistent •  Collaborative care (TelePain/ECHO) •  Cost is unsustainable •  Measurement based care (CPAIN/ PainTracker)
  • 57. EducaEon  is  important   Rosenblatt, 2011
  • 58. !"#$%&%'#(')$*+$#,-'.*/)(#$")*0',"*+$#,-,"$*/(%1$2*3"45678** Current Level of Knowledge1 Level of Interest in Learning 2 Mean (SD) Mean (SD) Assessment and management of genetic-biologic-psychological-social components 2.18 (1.0) 4.25 (0.85) commonly involved in development and maintenance of complex chronic pain disorders Pathophysiology of chronic pain versus acute pain 2.34 (1.0) 4.25 (0.85) Use, interpretation, and application of measurement based tools when completing a 1.72 (0.9) 4.16 (0.88) comprehensive pain assessment Multispecialty treatments and approaches for the care of chronic pain 2.12 (1.0) 4.37 (0.75) Types and roles of medications used for pain, including opioids and non-opioids. 2.29 (1.1) 4.56 (0.63) Types and role of non-medication treatment for chronic pain 2.23 (1.0) 4.52 (0.70) Common primary care clinical pain disorders 2.43 (1.0) 4.35 (0.85) Pain Medicine as a chronic illness specialty with knowledge and skills including 2.02 (1.1) 3.84 (1.06) diagnosis of complex complaints, complex medical and surgical illnesses, and both consultative and continuing multidisciplinary treatment. Learning more about pursuing a Residency in Pain Medicine - 2.85 (1.35) ! * 1 Scale = 1-Poor, 2-Fair, 3-Good, 4-Very Good, 5-Excellent 2 Scale = 1-Not Interested, 2-Little Interest, 3-Neutral, 4-Somewhat Interested, 5-Very Interested
  • 60. Take  Home  Message:   •  Coordinated,  collabora3ve,  measurement  based  model:   •  50%  decrease  in  deaths  from  opioids   •  65%  decrease  in  coun3es  par3cipa3ng  in  TelePain   •  56%  decrease  in  opioid  prescrip3on  rate   •  56%  decrease  in  opioid  related  ER  visits   •  50%  increase  in(see attached, for North American Spine Society 2012 Outstanding Paper Award)  global   health  ra3ng  1  year  aker  treatment  
  • 61. It  ain't  what  you   don't  know  that   gets  you  into   trouble.     It's  what  you  know   for  sure  that  just   ain't  so.   Mark  Twain